MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer

The objective of this study is to examine the safety profile and therapeutic efficacy of MRI-guided focused ultrasound microbubble therapy and radiotherapy in humans.

Trial Details

NCT ID
NCT05620290
Phase
PHASE1
Sponsor
Sunnybrook Health Sciences Centre
Status
RECRUITING
Cancer Type
Melanoma
Interventions
  • Definity
  • Sonalleve Focused Ultrasound Device
Locations (sample)
  • Toronto, Ontario, Canada|43.70643,-79.39864

Key Eligibility Criteria

  • Age ≥18 years
  • All biopsy-confirmed malignant melanoma of the skin and non melanoma skin cancer, including metastatic lesions.
  • Stage I-IV malignant melanoma and non melanoma skin cancer, per AJCC guidelines (8th Edition).
  • Patient referred for palliative radiotherapy/ standard radiotherapy/ neoadjuvant radiotherapy/ SBRT/ hypofractionation.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Melanoma Trials on Trialify →